Nouscom will present new phase 1b/2 data on its off‑the‑shelf cancer immunotherapy NOUS‑209 at the European Society for ...

ViiV Healthcare will present a broad range of clinical and real-world data at AIDS 2026, highlighting progress across its integrase strand transfer inhibitor portfolio, including long-acting medicines ...

Ardena has appointed Ariane de Ganck as Chief Scientific Officer, reinforcing its focus on scientific excellence across its ...

Jasper Therapeutics has completed its all‑stock acquisition of Kira Pharmaceuticals, creating a combined business focused on ...

EpilepsyGTx has partnered with ClearPoint Neuro to enable targeted delivery of its lead gene therapy candidate, EPY201, ahead ...

Braun has appointed Sophie Spencer as Social Value & ESG Specialist, recognising her rapid impact since joining the company ...

Bayer has welcomed final draft guidance from NICE recommending finerenone for adults in England and Wales with symptomatic chronic heart failure and a left ventricular ejection fraction of 40% or ...

Merck has announced that the European Commission has approved an update to the Erbitux (cetuximab) EU label, extending its ...

Eisai and Biogen have announced that the U.S. Food and Drug Administration has approved a supplemental biologics licence application for a once weekly subcutaneous initiation dose ...

The Scottish Medicines Consortium has recommended Astellas’s VEOZA (fezolinetant) 45 mg once daily for the treatment of ...

The Government’s recently announced NHS Modernisation Bill represents one of the most consequential attempts to reshape the ...

It is time to talk about GLP-1 as metabolic medicine ...